Table 1. Patient Characteristics.
| No-PORT (n=42) | PORT (n=38) | Total (n=80) | p value | |
|---|---|---|---|---|
| Age (yr) | 53.7±15.3 | 52.7±15.4 | 53.2±15.3 | 0.782 |
| Sex | 0.111 | |||
| Male | 24 (57.1) | 14 (36.8) | 38 (47.5) | |
| Female | 18 (42.9) | 24 (63.2) | 42 (52.5) | |
| ECOG | 0.624 | |||
| 0 | 18 (42.9) | 16 (42.1) | 34 (42.5) | |
| 1 | 24 (57.1) | 22 (57.9) | 45 (56.2) | |
| Pathology | 0.096 | |||
| Liposarcoma | 27 (64.3) | 15 (39.5) | 42 (52.5) | |
| Leiomyosarcoma | 6 (14.3) | 12 (31.6) | 18 (22.5) | |
| UPS | 3 (7.1) | 6 (15.8) | 9 (11.2) | |
| Other | 6 (14.3) | 5 (13.2) | 11 (13.8) | |
| FNCLCC grade | 0.432 | |||
| 1 | 11 (26.3) | 6 (15.8) | 17 (21.3) | |
| 2 | 8 (19.0) | 10 (26.3) | 18 (22.4) | |
| 3 | 8 (19.0) | 9 (23.7) | 17 (21.3) | |
| Unknown | 15 (35.7) | 13 (34.2) | 28 (35.0) | |
| Size | 0.599 | |||
| <10 cm | 10 (23.8) | 12 (31.6) | 22 (27.5) | |
| ≥10 cm | 32 (76.2) | 26 (68.4) | 58 (72.5) | |
| Stage | 0.358 | |||
| IA | 2 (4.8) | 3 (7.9) | 5 (6.2) | |
| IB | 22 (52.4) | 12 (31.6) | 34 (42.5) | |
| IIA | 0 (0.0) | 1 (2.6) | 1 (1.2) | |
| IIB | 7 (16.7) | 9 (23.7) | 16 (20.0) | |
| III | 11 (26.2) | 13 (34.2) | 24 (30.0) | |
| Resection margin | 0.053 | |||
| R0 | 29 (69.0) | 16 (42.1) | 45 (56.2) | |
| R1 | 9 (21.4) | 15 (39.5) | 24 (30.0) | |
| R2 | 4 (9.5) | 7 (18.4) | 11 (13.8) | |
| Adjuvant chemotherapy | 0.230 | |||
| No | 27 (64.3) | 30 (78.9) | 57 (71.2) | |
| Yes | 15 (35.7) | 8 (21.1) | 23 (28.8) |
PORT, postoperative radiotherapy; ECOG, Eastern Cooperative Oncology Group; UPS, undifferentiated pleomorphic sarcoma; FNCLCC, Fédération Nationale des Centres de Lutte Contre le Cancer.
Data are presented as mean±SD or number (%).